Ashraf Thabet
YOU?
Author Swipe
View article: Critical care pharmacists in intensive care units: A meta-analysis of their impact on mortality and adverse drug events
Critical care pharmacists in intensive care units: A meta-analysis of their impact on mortality and adverse drug events Open
Introduction: Critical care pharmacists (CCPs) are increasingly integrated into intensive care unit (ICU) teams to enhance medication safety and improve outcomes. However, their effect on mortality and adverse drug events (ADEs) remains in…
View article: Multiorgan-on-chip Platforms with Real-time Biosensors for Predictive Drug–Drug Interaction Screening in Polypharmacy Patients
Multiorgan-on-chip Platforms with Real-time Biosensors for Predictive Drug–Drug Interaction Screening in Polypharmacy Patients Open
Background: We propose a multiorgan-on-chip (MOOC) platform integrated with real-time biosensors for predictive drug–drug interaction (DDI) screening in polypharmacy patients, addressing the limitations of conventional static in vitro assa…
View article: Role of Vermicompost and algae Extract in Improving Growth and Fruit Quality of Mango (Keitt)
Role of Vermicompost and algae Extract in Improving Growth and Fruit Quality of Mango (Keitt) Open
This research, spanning the 2021 and 2022 seasons, aimed to explore the impact of vermicomposting on the growth and productivity of Mango trees (cv. Keitt) cultivated in sandy soil at Ahmed Orabi Agricultural region, El-Obour City, Cairo G…
View article: Single-cell atlas of the liver myeloid compartment with cure of chronic viral hepatitis
Single-cell atlas of the liver myeloid compartment with cure of chronic viral hepatitis Open
Background/Aims Chronic viral infections present serious public health challenges. Direct-acting antivirals (DAAs) are now able to cure nearly all patients infected with the hepatitis C virus (HCV), representing the only cure of a human ch…
View article: Data from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Data from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer Open
How genomic heterogeneity associated with acquired resistance to targeted agents affects response to subsequent therapy is unknown. We studied EGFR blockade in colorectal cancer to assess whether tissue and liquid biopsies can be integrate…
View article: Supplementary Figures S1 - S3, Tables S1 - S6 from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Supplementary Figures S1 - S3, Tables S1 - S6 from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer Open
Supplementary Figure S1. MEK1 K57 mutation confers resistance to anti-EGFR antibodies in CRC preclinical models. Supplementary Figure S2. Dual blockade of EGFR and MEK restores sensitivity to CRC cells expressing MEK1 K57N or K57T. Supplem…
View article: Supplementary Figures S1 - S3, Tables S1 - S6 from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Supplementary Figures S1 - S3, Tables S1 - S6 from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer Open
Supplementary Figure S1. MEK1 K57 mutation confers resistance to anti-EGFR antibodies in CRC preclinical models. Supplementary Figure S2. Dual blockade of EGFR and MEK restores sensitivity to CRC cells expressing MEK1 K57N or K57T. Supplem…
View article: Data from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer
Data from Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer Open
How genomic heterogeneity associated with acquired resistance to targeted agents affects response to subsequent therapy is unknown. We studied EGFR blockade in colorectal cancer to assess whether tissue and liquid biopsies can be integrate…
View article: Supplementary Table S3 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S3 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S3
View article: Supplementary Table S1 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S1 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S1
View article: Supplementary Table S5 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S5 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S5
View article: Supplementary Methods from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Methods from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Methods
View article: Supplementary Table S2 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S2 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S2
View article: Supplementary Methods from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Methods from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Methods
View article: Supplementary Table S4 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S4 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S4
View article: Supplementary Table S3 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S3 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S3
View article: Supplementary Table S2 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S2 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S2
View article: Supplementary Table S5 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S5 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S5
View article: Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Purpose:ctDNA offers a promising, noninvasive approach to monitor therapeutic efficacy in real-time. We explored whether the quantitative percent change in ctDNA early after therapy initiation can predict treatment response and progression…
View article: Supplementary Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Figures
View article: Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Purpose:ctDNA offers a promising, noninvasive approach to monitor therapeutic efficacy in real-time. We explored whether the quantitative percent change in ctDNA early after therapy initiation can predict treatment response and progression…
View article: Supplementary Table S4 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S4 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S4
View article: Supplementary Table S1 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Table S1 from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Table S1
View article: Supplementary Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Supplementary Data from Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers Open
Supplementary Figures
View article: Enhancing of Fruit Set %, Yield and Fruit Quality of “Washington” Navel Orange byDifferent Agrochemical Foliar Sprays in Application Times
Enhancing of Fruit Set %, Yield and Fruit Quality of “Washington” Navel Orange byDifferent Agrochemical Foliar Sprays in Application Times Open
The present investigation was conducted at private orchard at Barshome Kalyoubeya Governorate Egypt, on Washington Navel orange trees at fifteen years old during (2019 and 2020) seasons.This objective was to study the effect of foliar spra…
View article: Silicon and Selenium Impact on Fruit Set, Yield and Fruit Quality of Selmy DatePalms Grown Under Sandy Soil Conditions
Silicon and Selenium Impact on Fruit Set, Yield and Fruit Quality of Selmy DatePalms Grown Under Sandy Soil Conditions Open
This investigation was carried out during two consecutive seasons (2020 and 2021) on Selmy date palm cultivar grown on sandy soil at a confidential grove existing at point of 63 kilometer from Cairo-Alexandria desert road.The objective of …